Word: genericizing
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...finally the time has arrived for our little brother school to attempt some generic master-synthesis, some Hegelian superstructure...
...against itself. In a legal donnybrook over the price and patents of the tetracycline antibiotic, some 30 suits and countersuits have been filled by producers, buyers, sellers and the Federal Trade Commission. Criticism of the prices charged by big companies has led smaller ones to increase their output of generic drugs, which generally sell for half the price of brand-name products. Compounding the industry's frustration is the fact that, despite steady increases in research budgets, fewer than 20 new basic drugs will be introduced this year compared with 45 in 1960; the reasons lie more...
Also annoying is Sorensen's sparse use of examples--although he does cite the Cuban missile crisis of 1962 seventeen times. (He does not mention the Bay of Pigs.) Despite his personal intimacy with many decisions, Sorensen repeatedly speaks in the generic ("the most formidable debater is not necessarily the most informed; the reticent may sometimes be the wisest,") instead of the specific rendering insights so vage as to be meaningless...
...sufficiently identified, mention is made of a absent minded professor of comparative literature at Harvard. I am reminded that this might conceivably be taken as a reference to either a very great scholar recently dead or to one of my very great friends, Actually, of course, a generic academic type and no particular person was intended. I do not know why this department was selected. It is a mark of the inadvertence that in the earliest published version of the piece, the reference was to another department. John Kenneth Galbraith Paul M. Warburg Professor of Economics
...A.M.A.'s Council on Drugs has not committed itself on generic v. trade names but has just adopted a resolution favoring the labeling of prescriptions as a general practice. The A.M.A. believes that labeling is not always advisable with opiates and barbiturates, because of the danger of misuse by addicts or for suicide. There may also be exceptions for anti-cancer drugs, if the patient does not know what disease he has. But in general, the A.M.A. concludes: "The name of the drug and its strength on the label may save precious minutes and spell the difference between life...